Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug Interactions), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
Mov Disord off J Mov Disord Soc 35:14621466 McCarter SJ et al (2020b) Higher vitamin B12 level at Parkinsons disease diagnosis is associated with lower risk of future dementia
What does BPC-157 before and after look like for tendon injuries
That changed in 2023, when the FDA determined that 19 peptides posed significant safety risks and moved them to a de facto do not compound list
There's no prescription drug containing BPC-157 that's legally approved for human use in treating injuries, inflammation, gut issues, or pain
